# Immune Response Induced by a Vaccine Against Group B Streptococcus and Safety in Pregnant Women and Their Offsprings

> **NCT01446289** · PHASE2 · COMPLETED · sponsor: **Novartis** · enrollment: 86 (actual)

## Conditions studied

- Streptococcal Infection
- Gram-positive Bacterial Infection
- Bacterial Infection

## Interventions

- **BIOLOGICAL:** Group B Streptococcus Trivalent Vaccine
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT01446289
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2013-04
- **Final completion:** 2013-10
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2014-09-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01446289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01446289, "Immune Response Induced by a Vaccine Against Group B Streptococcus and Safety in Pregnant Women and Their Offsprings". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01446289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*